Search results
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 6 hours agoIt was one of several deals Pfizer struck to build a gene therapy portfolio, and is the first to...
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
BioPharma Dive via Yahoo Finance· 1 day agoAstraZeneca hit an important milestone last year, booking nearly $46 billion in revenue to meet an...
Who can get a Covid booster this spring and how can you book?
BBC via AOL· 1 week agoA protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna...
Canaan hires Pfizer executive, reels in $100M for biotech investing
BioPharma Dive via Yahoo Finance· 1 week agoThe firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 3 days agoModerna’s Spikevax vaccine was the third jab to be approved for use in the UK in January 2021 after...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 1 day agoBut he cautioned that even as Big Pharma companies buy into the space, they will still have to...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 20 hours agoThis was the first research project conducted to evaluate the immunity induced by the Pfizer...
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 23 hours agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
Insider Monkey via Yahoo Finance· 2 weeks agoIn this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in...
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
InvestorPlace· 3 days agoThis seems to be the case with pharmaceutical stocks. During the covid-19 pandemic, the pharma...